219 related articles for article (PubMed ID: 15306097)
1. Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues.
Weckermann D; Harzmann R
Eur Urol; 2004 Sep; 46(3):279-83; discussion 283-4. PubMed ID: 15306097
[TBL] [Abstract][Full Text] [Related]
2. Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer.
Kirby RS; Fitzpatrick JM; Clarke N
BJU Int; 2009 Dec; 104(11):1580-4. PubMed ID: 20053189
[TBL] [Abstract][Full Text] [Related]
3. Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group.
Garnick MB; Campion M
Mol Urol; 2000; 4(3):275-7. PubMed ID: 11062384
[TBL] [Abstract][Full Text] [Related]
4. The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.
Tomera K; Gleason D; Gittelman M; Moseley W; Zinner N; Murdoch M; Menon M; Campion M; Garnick MB
J Urol; 2001 May; 165(5):1585-9. PubMed ID: 11342922
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone: an update review of the antagonists versus agonists.
Van Poppel H; Klotz L
Int J Urol; 2012 Jul; 19(7):594-601. PubMed ID: 22416801
[TBL] [Abstract][Full Text] [Related]
6. New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.
Garnick MB; Mottet N
BJU Int; 2012 Aug; 110(4):499-504. PubMed ID: 22093775
[TBL] [Abstract][Full Text] [Related]
7. Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer.
Boccon-Gibod L; Iversen P; Persson BE
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1737-43. PubMed ID: 19954284
[TBL] [Abstract][Full Text] [Related]
8. Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer.
Debruyne F; Bhat G; Garnick MB
Future Oncol; 2006 Dec; 2(6):677-96. PubMed ID: 17155895
[TBL] [Abstract][Full Text] [Related]
9. Will GnRH antagonists improve prostate cancer treatment?
Huhtaniemi I; White R; McArdle CA; Persson BE
Trends Endocrinol Metab; 2009 Jan; 20(1):43-50. PubMed ID: 19008119
[TBL] [Abstract][Full Text] [Related]
10. The role of LHRH antagonists in the treatment of prostate cancer.
Crawford ED; Hou AH
Oncology (Williston Park); 2009 Jun; 23(7):626-30. PubMed ID: 19626830
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone-releasing hormone antagonists in prostate cancer.
Stricker HJ
Urology; 2001 Aug; 58(2 Suppl 1):24-7. PubMed ID: 11502441
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
Moreau JP; Delavault P; Blumberg J
Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109
[TBL] [Abstract][Full Text] [Related]
13. Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer.
Steinberg M
Clin Ther; 2009; 31 Pt 2():2312-31. PubMed ID: 20110043
[TBL] [Abstract][Full Text] [Related]
14. Degarelix for prostate cancer.
Doehn C; Sommerauer M; Jocham D
Expert Opin Investig Drugs; 2009 Jun; 18(6):851-60. PubMed ID: 19453267
[TBL] [Abstract][Full Text] [Related]
15. Degarelix: a new approach for the treatment of prostate cancer.
Persson BE; Kold Olesen T; Jensen JK
Neuroendocrinology; 2009; 90(3):235-44. PubMed ID: 19602868
[TBL] [Abstract][Full Text] [Related]
16. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
17. [Recent advance in luteinizing hormone-releasing hormone analogue therapy in management of prostate cancer].
Kawai K; Akaza H
Nihon Rinsho; 1998 Aug; 56(8):2108-13. PubMed ID: 9750517
[TBL] [Abstract][Full Text] [Related]
18. Utility of LHRH antagonists for advanced prostate cancer.
Moul JW
Can J Urol; 2014 Apr; 21(2 Supp 1):22-7. PubMed ID: 24775720
[TBL] [Abstract][Full Text] [Related]
19. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
Engel JB; Schally AV
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842
[TBL] [Abstract][Full Text] [Related]
20. GnRH antagonists in the treatment of advanced prostate cancer.
Pommerville PJ; de Boer JG
Can J Urol; 2010 Apr; 17(2):5063-70. PubMed ID: 20398443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
